Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03221283
Other study ID # MZhao-007
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 30, 2017
Est. completion date September 30, 2018

Study information

Verified date November 2018
Source Shanghai Mental Health Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The group music therapy will be used to treat female amphetamine-type stimulant (ATS) addiction


Description:

Amphetamine addicts are often accompanied by severe emotional problems and are difficult to control and regulate negative emotions by themselves.And the emotional problems are high risk factors of addicts relapse. Music therapy as the intervention is in order to improve amphetamine addicts' emotional status and the ability of emotion regulation. Self-rating Depression Scale(SDS), Self-rating Anxiety scale(SAS) will be used to investigate the emotion of participants. These methods will also be used to evaluate the efficacy of the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 30, 2018
Est. primary completion date August 30, 2018
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorder

- Junior high school degree or above

- Normal vision and hearing

- Have emotional problem

Exclusion Criteria:

- Other substance abuse or dependence in recent a years (except nicotine)

- Mental impairment, Intelligence Quotient (IQ) < 70

- Mental disorders

- Physical disease

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Music therapy group
The experimental group received 13 group music sessions over a three-month period. Different method of music therapy will be used to improve the emotion experience, emotion regulation, emotional control and emotional expression.

Locations

Country Name City State
China Shanghai Women's Compulsory Isolation Detoxification Center Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Shanghai Mental Health Center

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline Depression status assessed by Self-rating Depression Scale (SDS) at 4 months. evaluate all participants' depression status by Self-rating Depression Scale (SDS) Baseline, 2 months,4 months, and 7months
Secondary Anxiety status assessed by Self-rating Anxiety Scale (SAS) evaluate all participants' anxiety status by Self-rating Anxiety Scale (SAS) Baseline, 2 months,4 months, and 7months
Secondary Change from Baseline Craving for ATS assessed by Visual Analog Scales (VAS) evaluate all participants' craving for ATS by Visual Analog Scales (VAS) Baseline, 2 months,4 months, and 7months
Secondary Empathy ability assessed by Interpersonal Reactivity Index-C(IRI-C) evaluate all participants' Empathy ability by Interpersonal Reactivity Index-C(IRI-C) Baseline, 2 months,4 months, and 7months
Secondary Motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES) evaluate all participants' motivation for treatment assessed by Stages of Change Readiness and Treatment Eagerness Scale(SOCRATES) Baseline, 2 months,4 months, and 7months
Secondary Change from Baseline emotional status assessed by emotional STROOP paradigm evaluate all participants' emotional status by emotional STROOP paradigm Baseline, 2 months,4 months, and 7months
Secondary Sleep status assessed by Pittsburgh Sleep Quality Index(PSQI) evaluate all participants' sleep status by Pittsburgh Sleep Quality Index(PSQI) Baseline, 2 months,4 months, and 7months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05535101 - Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder N/A
Not yet recruiting NCT02836756 - Cannabidiol as a New Intervention for Amphetamine Dependence Phase 2
Completed NCT03318081 - The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction N/A
Withdrawn NCT02952196 - Cannabioids as a New Intervention for Amphetamine Dependence Phase 2
Completed NCT02285556 - The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus N/A
Completed NCT02713815 - Novel Intervention for Amphetamine-type Stimulants Addiction N/A
Completed NCT00713479 - An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers Phase 1
Completed NCT04993300 - Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction N/A
Completed NCT02950376 - The Novel Addiction Assessment Study in Synthetic Drugs Addiction
Recruiting NCT04531384 - Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders. N/A
Recruiting NCT04687566 - Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction Phase 2/Phase 3